Skip to content

The Cognitive Functional Therapy in foot disorders

Effectiveness of Cognitive Functional Therapy in patients with Plantar Fasciopathy: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-57vgbmg
Enrollment
Unknown
Registered
2025-03-17
Start date
2024-10-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis

Interventions

The intervention group will undergo cognitive functional therapy, which is an integrated behavioral approach to individualize the management of individuals with chronic complaints, using a multidimens
pain experience and relief with positions, postures, movement, weight-bearing, or rest
beliefs about the cause of their pain, prognosis, and severity of symptoms
imaging studies and the participant’s view of the impact of the outcome on their pain
emotional responses to pain, such as fear and distress
behavioral responses to pain, such as coping, avoidance, postural and movement habits, and lifestyle
feared and avoided painful functional activities
general health, fatigue levels, and comorbidities
perceived barriers to adopting a healthy lifestyle
and relevant personal goals. The therapist will listen openly to the participant’s story without interruption and summarize the story at the end to assess its validity. The physical examinat
I03.350

Sponsors

Departamento de Ciências do Movimento Humano
Lead Sponsor
Centro Universitário Faculdade de Medicina do ABC
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants of both sexes; aged 18 years or older; with complaints of plantar pain greater than or equal to 3 out of 10 points on the numerical pain scale for at least 3 months; reproduced with the first step in the morning and/or in activities with increased weight support, for example, standing; pain on palpation of the medial calcaneal tubercle and/or proximal plantar fascia will be included in the study; Patients who present with bilateral pain will be considered on the side with greater pain

Exclusion criteria

Exclusion criteria: Participants who have had musculoskeletal disease in the lower limbs in the last 6 months; systemic musculoskeletal disease; previous surgery on the lower limbs and spine; diabetes; pregnancy; having received corticosteroid application in the plantar fascia in the last 6 months will be excluded

Design outcomes

Primary

MeasureTime frame
A reduction of up to one point in pain intensity on the numerical pain scale is expected at the eighth week after randomization

Secondary

MeasureTime frame
Participant satisfaction with the proposed treatment is expected to be assessed using the global treatment effect scale in the eighth week after randomization;It is expected to find a reduction in kinesiophobia, assessed using the Tampa Kinesiophobia Scale, and pain catastrophizing, assessed using the pain catastrophizing scale in the eighth week after randomization, three months and six months after randomization;Pain reduction of up to one point on the numerical pain scale and improvement in performance in three functional positions are expected at eight weeks after randomization, three months and six months after randomization;Pain reduction in the last seven days of up to one point on the numerical pain scale is expected at three and six months after randomization;Improvement in disability is expected, assessed using the patient-specific functional scale at eight weeks after randomization, three and six months after randomization;Improvement in psychosocial aspects and sleep is expected, assessed through the brief psychosocial scale in the eighth week after randomization, three months and six months after randomization

Countries

Brazil

Contacts

Public ContactAndré Persiane

Centro Universitário FMABC

fisio.andresetti@gmail.com+55 (11) 49935400

Outcome results

None listed

Source: REBEC (via WHO ICTRP)